SG Americas Securities LLC Trims Stock Position in Huron Consulting Group Inc. (NASDAQ:HURN)

SG Americas Securities LLC decreased its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 28.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 3,603 shares of the business services provider’s stock after selling 1,439 shares during the period. SG Americas Securities LLC’s holdings in Huron Consulting Group were worth $392,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Covestor Ltd lifted its stake in shares of Huron Consulting Group by 26,500.0% during the first quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock valued at $26,000 after buying an additional 265 shares during the period. Ashton Thomas Private Wealth LLC purchased a new position in shares of Huron Consulting Group during the second quarter valued at approximately $28,000. Daiwa Securities Group Inc. lifted its stake in shares of Huron Consulting Group by 800.0% during the first quarter. Daiwa Securities Group Inc. now owns 1,800 shares of the business services provider’s stock valued at $174,000 after buying an additional 1,600 shares during the period. Dakota Wealth Management purchased a new position in shares of Huron Consulting Group during the second quarter valued at approximately $219,000. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Huron Consulting Group by 39.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,555 shares of the business services provider’s stock valued at $263,000 after buying an additional 724 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Analyst Upgrades and Downgrades

HURN has been the topic of several recent analyst reports. Benchmark reissued a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, July 31st. Barrington Research reaffirmed an “outperform” rating and set a $137.00 price target on shares of Huron Consulting Group in a research report on Monday, September 9th. Finally, StockNews.com raised shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research report on Saturday, August 3rd. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.75.

Insider Transactions at Huron Consulting Group

In other news, CEO C. Mark Hussey sold 4,000 shares of the stock in a transaction on Monday, August 12th. The shares were sold at an average price of $103.13, for a total value of $412,520.00. Following the completion of the sale, the chief executive officer now owns 81,081 shares of the company’s stock, valued at $8,361,883.53. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director H Eugene Lockhart sold 1,042 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.61, for a total transaction of $106,919.62. Following the completion of the sale, the director now directly owns 30,924 shares of the company’s stock, valued at approximately $3,173,111.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO C. Mark Hussey sold 4,000 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $103.13, for a total transaction of $412,520.00. Following the sale, the chief executive officer now directly owns 81,081 shares of the company’s stock, valued at approximately $8,361,883.53. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,168 shares of company stock valued at $1,170,515 over the last 90 days. Corporate insiders own 2.02% of the company’s stock.

Huron Consulting Group Stock Performance

Shares of HURN stock opened at $107.70 on Friday. Huron Consulting Group Inc. has a one year low of $84.26 and a one year high of $115.65. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93. The company has a 50 day moving average price of $106.74 and a 200 day moving average price of $99.67. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 31.04 and a beta of 0.61.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, topping the consensus estimate of $1.48 by $0.20. Huron Consulting Group had a net margin of 5.46% and a return on equity of 20.44%. The firm had revenue of $371.70 million during the quarter, compared to analyst estimates of $374.33 million. During the same quarter in the prior year, the business posted $1.38 earnings per share. Huron Consulting Group’s revenue for the quarter was up 7.2% compared to the same quarter last year. Sell-side analysts anticipate that Huron Consulting Group Inc. will post 5.95 EPS for the current year.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.